Edition:
United Kingdom

Summit Therapeutics PLC (SMMT.OQ)

SMMT.OQ on NASDAQ Stock Exchange Global Market

11.68USD
16 Feb 2018
Change (% chg)

$-0.50 (-4.11%)
Prev Close
$12.18
Open
$12.05
Day's High
$12.35
Day's Low
$11.58
Volume
7,604
Avg. Vol
14,562
52-wk High
$16.59
52-wk Low
$8.80

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.60 January 17 Feb 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 2 2 2
(2) OUTPERFORM 4 4 3 3
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.57 1.67 1.60 1.60

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Apr-18 5 3.75 8.76 2.10 1.00
Quarter Ending Jul-18 5 5.09 14.30 2.10 1.00
Year Ending Jan-18 6 35.46 42.24 31.60 8.97
Year Ending Jan-19 7 18.38 43.30 8.40 9.08
Earnings (per share)
Quarter Ending Apr-18 2 -0.60 -0.51 -0.68 --
Quarter Ending Jul-18 2 -0.55 -0.42 -0.68 --
Year Ending Jan-18 1 -0.41 -0.41 -0.41 -1.11
Year Ending Jan-19 2 -1.53 -1.49 -1.58 -0.38

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Oct-17 2.99 2.29 0.70 23.35
Quarter Ending Jul-17 18.69 25.01 6.32 33.78
Quarter Ending Apr-17 1.33 2.24 0.90 67.70
Quarter Ending Jan-17 1.08 2.17 1.10 102.33
Quarter Ending Oct-16 8.03 0.70 7.33 91.25
Earnings (per share)
Quarter Ending Oct-17 -0.58 -0.20 0.38 -65.52
Quarter Ending Jul-17 0.34 1.10 0.75 218.84
Quarter Ending Jan-17 -0.48 -0.50 0.02 -4.17
Quarter Ending Oct-16 3.01 -0.45 3.46 114.95
Quarter Ending Jul-16 -0.65 -0.65 0.00 -0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Apr-18 3.75 4.17 4.69 4.85 1.00
Quarter Ending Jul-18 5.09 5.83 6.73 6.90 1.00
Year Ending Jan-18 35.46 36.19 36.64 35.60 8.97
Year Ending Jan-19 18.38 20.04 17.57 22.09 9.08
Earnings (per share)
Quarter Ending Apr-18 -0.60 -0.68 -- -0.49 --
Quarter Ending Jul-18 -0.55 -0.68 -- -0.57 --
Year Ending Jan-18 -0.41 -0.41 -- -0.56 -1.11
Year Ending Jan-19 -1.53 -1.49 -- -1.05 -0.38

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Apr-18 0 0 0 0
Quarter Ending Jul-18 0 0 1 0
Year Ending Jan-18 0 0 0 0
Year Ending Jan-19 0 0 1 0
Earnings
Quarter Ending Apr-18 0 0 -- --
Quarter Ending Jul-18 0 0 -- --
Year Ending Jan-18 0 0 -- --
Year Ending Jan-19 0 0 -- --